AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript

ABCL earnings call for the period ending December 31, 2023.

Related Keywords

United States , Canada , United Kingdom , America , British , Canadian , Robyn Karnauskas , Piper Sandler , Puneet Souda , Robyn Karnauskas Truist , Abcellera Biologics , Carl Hansen , Evan Seigerman , Steve Willey , Steve Dechert , Tryn Stimart , Allison Bratzel Piper Sandler , Allison Bratzel , Steven Mah , Steve Dechert Keybanc , Goldman Sachs , Amgen , Canada Strategic Innovation Fund , Abcellera Biologics Inc , Keycorp , Exchange Commission , Steve Willey Stifel Financial Corp , Andrew Booth , Safe Harbor , Private Securities Litigation Reform Act , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , British Columbia , Arsenal Bio , Trianni Mouse , Strategic Innovation , Andrea Tan , Maybei Ll , Banc Capital Markets , Stifel Financial , Keybanc Capital Markets , Chief Executive Officer , Thanks Andrea , Clinical Development , Arsenal ,